Virbac SA: Promising Growth Prospects and Attractive Valuation Justify Buy Rating

In a report released today, Valentin Paul Jahan from Stifel Nicolaus upgraded Virbac SA (0NM7 – Research Report) to a Buy, with a price target of €390.00.

Valentin Paul Jahan has given his Buy rating due to a combination of factors that highlight Virbac SA’s promising growth prospects and attractive valuation. Despite a temporary slowdown in profit growth expected in the first half of 2025, the company has shown reassuring performance in the latter half of 2024, slightly surpassing expectations. This performance, coupled with the confirmation of its guidance for 2025, suggests a solid foundation for future growth.
Looking ahead, Virbac is poised to continue outperforming its market, particularly in specialty products and pet food, and in emerging markets like India and China. The company’s strategic plans to enhance its product portfolio and improve productivity through significant R&D and capital expenditures are expected to drive double-digit EPS growth by 2030. With valuation multiples now at attractive levels, the risk/reward profile has improved, justifying the upgrade to a Buy rating with a price target of €390.